The extracellular cardiac purine metabolome in sepsis

Shock

Volumn 28, Issue 3, 2007, Pages 259-264

  Law, William R ^a   Conlon, Beth A ^b   Ross, James D ^b  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Adenosine; Adenosine deaminase; Heart; Purines; Sepsis

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE PHOSPHATE; CYCLIC AMP; GUANOSINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSINE PHOSPHATE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NUCLEOSIDE DERIVATIVE; PURINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

AUTOCRINE EFFECT; CARDIOMYOPATHY; CELL TYPE; CONGESTIVE HEART FAILURE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXERCISE; FIBROBLAST; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HUMAN; INFLAMMATION; MACROPHAGE; METABOLIC REGULATION; METABOLOMICS; MONOCYTE; NONHUMAN; PARACRINE SIGNALING; PERITONITIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PURINE METABOLISM; RESPIRATORY BURST; SEPSIS; SHORT SURVEY;

ADENOSINE; ADENOSINE DEAMINASE; ALLOSTERIC REGULATION; ANIMALS; HUMANS; MACROPHAGES, PERITONEAL; MYOCARDIUM; PURINES; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; SEPSIS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548022566     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000232587.61871.1b     Document Type: Short Survey

References (53)

1. Broch OJ, Ueland PM: Regional and subcellular distribution of S-adenosylhomocysteine hydrolase in the adult rat brain. J Neurochem 35:484-488, 1980.
2. Schrader J, Schutz W, Bardenheuer H: Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart. Biochem J 196:65-70, 1981.
3. Schubert P, Komp W, Kreutzberg GW: Correlation of 5′-nucleotidase activity and selective transneuronal transfer of adenosine in the hippocampus. Brain Res 168:419-424, 1979.
4. Zimmermann H, Braun N, Kegel B, Heine P: New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem Int 32:421-425, 1998.
5. Deussen A: Metabolic flux rates of adenosine in the heart. Naunyn Schmiedebergs Arch Pharmacol 362:351-363, 2000.
6. Schutz W, Schrader J, Gerlach E: Different sites of adenosine formation in the heart. Am J Physiol 240:H963-H970, 1981.
7. Bardenheuer H, Schrader J: Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol 250:H173-H180, 1986.
8. Sollevi A, Fredholm BB: Role of adenosine in adipose tissue circulation. Acta Physiol Scand 112:293-298, 1981.
9. Arch JRS, Newsholme EA: The control of the metabolism and the hormonal role of adenosine. Essays Biochem 14:82-123, 1994.
10. Deussen A: Quantitative integration of different sites of adenosine metabolism in the heart. Ann Biomed Eng 28:877-883, 2000.
11. Jackson EK, Raghvendra DK: The extracellular cyclic AMP-adenosine pathway in renal physiology. Annu Rev Physiol 66:571-599, 2004.
12. Moriwaki Y, Yamamoto T, Higashino K: Enzymes involved in purine metabolism-a review of histochemical localization and functional implications. Histol Histopathol 14:1321-1340, 1999.
13. Bowie A, O'Neill LA: Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59:13-23, 2000.
14. Deitch EA, Bridges W, Baker J, Ma JW, Ma L, Grisham MB, Granger N, Specian RD, Berg R: Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery 104:191-198, 1988.
15. Deitch EA, Taylor M, Grisham M, Ma L, Bridges W, Berg R: Endotoxin induces bacterial translocation and increases xanthine oxidase activity. J Trauma 29:1679-1683, 1989.
16. Xu D, Qi L, Guillory D, Cruz N, Berg R, Deitch EA: Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J Trauma 34:676-683, 1993.
17. Adanin S, Yalovetskiy IV, Nardulli BA, Sam AD II, Jonjev ZS, Law WR: Inhibiting adenosine deaminae modulates the systemic inflammatory response syndrome in endotoxemia and sepsis. Am J Physiol 282:R1324-R1332, 2002.
18. Si QS, Nakamura Y, Kataoka K: Adenosine inhibits superoxide production in rat peritoneal macrophages via elevation of cAMP level. Immunopharmacology 36:1-7, 1997.
19. Dubey RK, Gillespie DG, Mi Z, Jackson EK: Cardiac fibroblasts express the cAMP-adenosine pathway. Hypertension 36:337-342, 2000.
20. Dubey RK, Gillespie DG, Mi Z, Jackson EK: Endogenous cyclic AMP-adenosine pathway regulates cardiac fibroblast growth. Hypertension 37:1095-1100, 2001.
21. Azzawi M, Hasleton PS, Kan SW, Hillier VF, Quigley A, Hutchinson IV: Distribution of myocardial macrophages in the normal human heart. J Anat 191(Pt 3):417-423, 1997.
22. Conlon BA, Law WR: Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses. Clin Exp Immunol 138:14-20, 2004.
23. Meldrum DR: Tumor necrosis factor in the heart. Am J Physiol 274:R577-R595, 1998.
24. Higuchi Y, Otsu K, Nishida K, Hirotani S, Nakayama H, Yamaguchi O, Matsumura Y, Ueno H, Tada M, Hori M: Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. J Mol Cell Cardiol 34:233-240, 2002.
25. Meldrum DR, Dinarello CA, Cleveland JC Jr, Cain BS, Shames BD, Meng X, Harken AH: Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism. Surgery 124:291-296, 1998.
26. Li C, Ha T, Liu L, Browder W, Kao RL: Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart. Surgery 127:161-169, 2000.
27. Meldrum DR, Cain BS, Cleveland JC Jr, Meng X, Ayala A, Banerjee A, Harken AH: Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation. Immunology 92:472-477, 1997.
28. Wagner DR, Combes A, McTiernan C, Sanders VJ, Lemster B, Feldman AM: Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha. Circ Res 82:47-56, 1998.
29. Wagner DR, Kubota T, Sanders VJ, McTiernan CF, Feldman AM: Differential regulation of cardiac expression of IL-6 and TNF-alpha by A2- and A3-adenosine receptors. Am J Physiol 276:H2141-H2147, 1999.
30. Wagner DR, McTiernan C, Sanders VJ, Feldman AM: Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart. Circulation 97:521-524, 1998.
31. Hirschhorn R, Ratech H: Isozymes of adenosine deaminase. Isozymes Curr Top Biol Med Res 4:131-157, 1980.
32. Gakis C: Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 9:632-633, 1996.
33. Gakis C, Calia G, Naitana A, Pirino D, Serru G: Serum adenosine deaminase activity in HIV positive subjects. A hypothesis on the significance of ADA2. Panminerva Med 31:107-113, 1989.
34. Akeson AL, Wiginton DA, Dusing MR, States JC, Hutton JJ: Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts. J Biol Chem 263:16291-16296, 1988.
35. Dusing MR, Brickner AG, Thomas MB, Wiginton DA: Regulation of duodenal specific expression of the human adenosine deaminase gene. J Biol Chem 272:26634-26642, 1997.
36. Zavialov AV, Engstrom A: Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity. Biochem J 391:51-57, 2005.
37. Law WR, Conlon BA, Valli VE: Therapeutic potential for transient inhibition of adenosine deaminase in systemic inflammatory response syndrome. Crit Care Med 31:1475-1481, 2003.
38. Motew SJ, Sam AD II, Mourelatos MG, Sharma AC, Alden KJ, Ferguson JL, Law WR: Adenosine receptor antagonism affects regional resting vascular resistance during rat peritoneal sepsis. J Surg Res 80:326-332, 1998.
39. Powers FM, Farias S, Minami H, Martin AF, Solaro RJ, Law WR: Cardiac myofilament protein function is altered during sepsis. J Mol Cell Cardiol 30:967-978, 1998.
40. Sam AD II, Sharma AC, Rice AN, Ferguson JL, Law WR: Adenosine and nitric oxide regulate regional vascular resistance via interdependent and independent mechanisms during sepsis. Crit Care Med 28:1931-1939, 2000.
41. Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, Ferguson JL: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 29:1469-1477, 1997.
42. Becker BF, Gerlach E: Uric acid, the major catabolite of cardiac adenine nucleotides and adenosine, originates in the coronary endothelium. In Gerlach E, Becker BF (eds.): Topics and Perspectives in Adenosine Research. Berlin: Heidelberg, pp 209-222, 1987.
43. Abd-Elfattah AS, Jessen ME, Hanan SA, Tuchy G, Wechsler AS: Is adenosine 5′-triphosphate derangement or free-radical-mediated injury the major cause of ventricular dysfunction during reperfusion? Role of adenine nucleoside transport in myocardial reperfusion injury. Circulation 82(5 Suppl): IV341-IV350, 1990.
44. Nie Z, Mei Y, Ford M, Rybak L, Marcuzzi A, Ren H, Stiles GL, Ramkumar V: Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B. Mol Pharmacol 53:663-669, 1998.
45. Xia Y, Khatchikian G, Zweier JL: Adenosine deaminase inhibition prevents free radical-mediated injury in the postischemic heart. J Biol Chem 271:10096-10102, 1996.
46. Cohen ES, Law WR, Easington CR, Cruz KQ, Nardulli BA, Balk RA, Parillo JE, Hollenberg SM: Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis. Am J Respir Crit Care Med 166:16-20, 2002.
47. Ruiz MA, Escriche M, Lluis C, Franco R, Martin M, Andres A, Ros M: Adenosine A(1) receptor in cultured neurons from rat cerebral cortex: colocalization with adenosine deaminase. J Neurochem 75:656-664, 2000.
48. Saura CA, Mallol J, Canela EI, Lluis C, Franco R: Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 273:17610-17617, 1998.
49. Ciruela F, Saura C, Canela EI, Mallol J, Lluis C, Franco R: Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett 380:219-223, 1996.
50. Herrera C, Casado V, Ciruela F, Schofield P, Mallol J, Lluis C, Franco R: Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol Pharmacol 59:127-134, 2001.
51. Franco R, Valenzuela A, Lluis C, Blanco J: Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol Rev 161:27-42, 1998.
52. Franco R, Casado V, Ciruela F, Saura C, Mallol J, Canela EI, Lluis C: Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 52:283-294, 1997.
53. Franco R, Casado V, Ciruela F, Mallol J, Lluis C, Canela EI: The cluster-arranged cooperative model: a model that accounts for the kinetics of binding to A1 adenosine receptors. Biochemistry 35:3007-3015, 1996.